Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




T-Cell Receptor Sequencing Reveals Novel Biomarkers For Ovarian Cancer

By LabMedica International staff writers
Posted on 22 Jun 2016
Deep T-cell receptor (TCR) sequencing has been used to evaluate the clonal composition of tumor-infiltrating lymphocytes and identify novel prognostic biomarkers in ovarian cancer.

The ability of tumor-infiltrating lymphocytes (TILs) such as T-cells to produce multitudes of clones that overwhelm and effectively control cancer cells has been demonstrated, but the significance of the composition of T-cell repertories is unknown.

Scientists at Roswell Park Cancer Institute (Buffalo, NY, USA) analyzed 198 blood samples from 99 women with ovarian cancer using the ImmunoSEQ platform (Adaptive Biotechnologies, South San Francisco, CA, USA). More...
Spontaneous immune responses were assessed by measuring serum antibodies against ovarian cancer-associated antigens, such as NY-ESO-1, that are not expressed in normal body tissues, but are expressed in cancers. The degree of CD3+ and CD8+T-cell infiltration was evaluated by immunohistochemistry.

The team found 10.3 million unique clones in peripheral blood and 1.4 million unique clones in tumors. Poor overall survival was associated with higher T-cell diversity, that is, higher clone-to-TIL ratios. While higher TIL levels conferred a favorable prognosis in patients with spontaneous immune response to tumor antigens, they were a poor prognostic factor in patients who did not experience an immune response.

The authors concluded that the integration of T-cell repertoire diversity in tumor and peripheral blood with density of TILs identified clone/CD3 TIL and clone/CD4 TIL ratios; TIL clonality; and the degree of overlap of peripheral and TIL repertoire as novel prognostic biomarkers in ovarian cancer. The presence of pre-existing anti-tumor immunity shapes the correlation of TIL clonality and peripheral/TIL overlap with clinical outcome.

Kunle Odunsi, MD, PhD, a Professor of Gynecologic Oncology, and lead author of the study said, “While the presence of lymphocytes in tumors is often associated with better clinical outcomes, this study adds clarity on the diversity of T cells within the tumor environment and their influence on ovarian cancer outcomes.” The study was presented on June 6, 2016, at the American Society of Clinical Oncology (ASCO) 52nd Annual Meeting held in Chicago, IL, USA.

Related Links:
Roswell Park Cancer Institute
Adaptive Biotechnologies

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Gold Member
Platelet Function Analyzer
PL-12
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.